Timothy Mark Dyer 13D/13G Filings for Addex Therapeutics Ltd (ADXN)

Timothy Mark Dyer 13D and 13G filings for Addex Therapeutics Ltd:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-06-23
4:00 pm
Purchase
2025-06-20 13D Addex Therapeutics Ltd
ADXN
Timothy Mark Dyer 18,208,437
12.940%
1,345,082increase
(+7.98%)
Filing
2023-11-29
4:00 pm
Purchase
2023-11-27 13D Addex Therapeutics Ltd
ADXN
Timothy Mark Dyer 16,863,355
14.160%
16,863,355increase
(New Position)
Filing